Free radicals in heart failure: therapeutic targets for old and new drugs.
Zafari
A Maziar
AM
Emory University School of Medicine, Department of Medicine, Division of Cardiology, Atlanta, GA 30322, USA. azafari@emory.edu
Harrison
David G
DG
D000975:Antioxidants / Q000378:metabolism / Q000627:therapeutic use*; D004730:Endothelium, Vascular / Q000502:physiology; D005609:Free Radicals / Q000378:metabolism*; D006333:Heart Failure / Q000188:drug therapy* / Q000209:etiology / Q000503:physiopathology; D006801:Humans; D009206:Myocardium / Q000378:metabolism; D009569:Nitric Oxide / Q000502:physiology; D018384:Oxidative Stress / Q000187:drug effects* / Q000502:physiology; D017382:Reactive Oxygen Species
D000975:Antioxidants; D005609:Free Radicals; D017382:Reactive Oxygen Species; D009569:Nitric Oxide